Handelsavisen
prelaunch
Companies Healthcare 199550.KQ
19
199550.KQ KOSDAQ Advanced Medical Equipment & Technology

199550.Kq

$3 825,00
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
0,00 %
Op margin
-46,2 %
ROE
-48,4 %
Net margin
-41,8 %
Debt / equity
0,45
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

The company operates in the healthcare equipment industry, specializing in the design, development, and sale of advanced medical equipment and technology.

Business. The company operates in the healthcare equipment industry, specializing in the design, development, and sale of advanced medical equipment and technology.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryAdvanced Medical Equipment & Technology
ActivityHealthcare Equipment
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
-48,4 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 199550.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 199550.KQ. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    The company operates in the healthcare equipment industry, specializing in the design, development, and sale of advanced medical equipment and technology.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryAdvanced Medical Equipment & Technology
    ActivityHealthcare Equipment
    AI synthesis
    GENERATED

    The company's capital structure is characterized by a debt-to-equity ratio of 0.45, indicating a relatively conservative leverage position. However, the company's liquidity is assessed as medium, with a current ratio of 2.31, suggesting it can cover its short-term obligations but with limited excess capacity. The company holds cash and equivalents of KRW 5,515,372,950, but this is offset by long-term debt of KRW 10,044,157,310, resulting in a net cash position that is negative after subtracting total debt.

    Profitability metrics are concerning, with a return on equity of -48.44% and a return on assets of -29.39%. These figures indicate that the company is not generating returns for its shareholders or effectively utilizing its assets. The operating loss of KRW 11,873,719,200 and net loss of KRW 10,743,981,000 further underscore the company's financial distress. Gross profit of KRW 9,867,677,660 is insufficient to cover operating expenses, highlighting the need for cost optimization or revenue growth.

    The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of diversification increases exposure to regional economic fluctuations and regulatory changes. The absence of segment or geographic breakdowns in the input data limits the ability to assess the company's risk profile in detail.

    The company's growth trajectory is negative, with a net loss and declining operating cash flow. The operating cash flow of -KRW 6,392,070,450 and free cash flow of -KRW 9,688,732,390 indicate that the company is not generating sufficient cash from operations to sustain its activities. The capital expenditure of -KRW 714,873,390 suggests ongoing investment, but without corresponding revenue growth, this may exacerbate financial strain.

    Risk factors include liquidity constraints and the potential for dilution, although the risk of dilution is assessed as low. The company's negative net cash position and operating losses increase the risk of financial distress. The risk assessment highlights the need for improved cash flow generation and cost management to mitigate these risks.

    Recent events, as disclosed in the latest financial filings, include a significant operating loss and net loss. The company has not provided detailed explanations for these losses, but the negative cash flows and high debt levels suggest operational challenges. No recent transcripts or filings provide additional context on strategic initiatives or cost-cutting measures.

    Key takeaways
    • The company is experiencing significant financial distress, with a net loss and negative cash flows.
    • The debt-to-equity ratio is relatively low, but the company's liquidity is constrained by negative net cash after debt.
    • Profitability metrics are severely negative, indicating poor returns on equity and assets.
    • The company's revenue and operations are not diversified, increasing exposure to regional and sector-specific risks.
    • The company's growth trajectory is negative, with no signs of improvement in operating performance.

    Bull / Bear case

    analysis pipeline
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $3 825,00
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $22.18B
    Net cash
    -$4.53B
    Current ratio
    2.3
    Debt / equity
    0.5
    ROA
    -29.4%
    ROE
    -48.4%
    Cash conversion
    59.0%
    CapEx / revenue
    -2.8%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin-46,2 %Below median
    Net Margin-41,8 %Below median
    ROE-48,4 %Bottom quartile
    Capex / Rev-2,8 %Above median
    D/E0,45Below median
    Cash Conv0,59Below median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • 199550.KQ Market data — financials · 2026-05-26

    Ownership & reference

    Leadership

    • Chang Jin LeePresident, Chief Executive Officer

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    199550.KQCanonical
    KOSDAQ · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage